3′-Deoxy-3′-<sup>18</sup>F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab

J. von Schwarzenberg(Medical University of Vienna), Wei Chen(Tulane University), Whitney B. Pope(University of California, Los Angeles), Daniel Silverman(University of California, Los Angeles), Timothy F. Cloughesy(University of California, Los Angeles), Magnus Dahlbom(University of California, Los Angeles), Nagichettiar Satyamurthy, Michael E. Phelps(National Academy of Engineering), Cheri Geist(University of California, Los Angeles), Johannes Czernin(University of California, Los Angeles), Benjamin M. Ellingson(University of California, Los Angeles)
Journal of Nuclear Medicine
December 12, 2011
Cited by 133


Related Papers